Urinary CXCL-9 outperforms TNF-α for non-invasive diagnosis of immune checkpoint inhibitor–associated acute interstitial nephritis
Increased urinary CXCL-9 was superior to TNF-α as a biomarker for the non-invasive diagnosis of ICI-AIN, even after prior corticosteroid exposure, highlighting its promise as clinical diagnostic tool.
Authors
- Gurparneet Kaur Sohi
- Coraima Claudia Nava Chavez
- Sheila Rubio Bermejo
- Lisa A. Kottschade (ORCID: https://orcid.org/0000-0001-8922-2619)
- María José Soler (ORCID: https://orcid.org/0000-0003-3621-0766)
- S. Markovic
- Callen D. Giesen
- Omar Al Refai
- Nelson Leung
- John C Lieske
- Victor Cuenca Narvaez
- Sandra M Herrmann
Institutions
- Hebron University (PS)
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1093/ndt/gfag016
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 24.20